Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease von Rosario, M., Dirks, N. L., Gastonguay, M. R., Fasanmade, A. A., Wyant, T., Parikh, A., Sandborn, W. J., Feagan, B. G., Reinisch, W., Fox, I.

Volltext

Population Pharmacokinetics of Fluconazole in Young Infants von WADE, K. C, WU, D, GASTONGUAY, M. R, BARRETT, J. S, KAUFMAN, D. A, WARD, R. M, BENJAMIN, D. K, SULLIVAN, J. E, RAMEY, N, JAYARAMAN, B, HOPPU, K, ADAMSON, P. C

Volltext

Population pharmacokinetics of ε-aminocaproic acid in adolescents undergoing posterior spinal fusion surgery von Stricker, P.A., Gastonguay, M.R., Singh, D., Fiadjoe, J.E., Sussman, E.M., Pruitt, E.Y., Goebel, T.K., Zuppa, A.F.

Volltext

Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery von Stricker, P.A., Zuppa, A.F., Fiadjoe, J.E., Maxwell, L.G., Sussman, E.M., Pruitt, E.Y., Goebel, T.K., Gastonguay, M.R., Taylor, J.A., Bartlett, S.P., Schreiner, M.S.

Volltext

Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems Model von Eudy, RJ, Gastonguay, MR, Baron, KT, Riggs, MM

Volltext

Quantitative Assessment of Exposure–Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation von Ravva, P, Gastonguay, M R, French, J L, Tensfeldt, T G, Faessel, H M

Volltext

Mathematics for Understanding Disease von Bies, RR, Gastonguay, MR, Schwartz, SL

Volltext

Population Pharmacokinetic Modeling of Pantoprazole in Pediatric Patients From Birth to 16 Years von Knebel, W., Tammara, B., Udata, C., Comer, G., Gastonguay, M. R., Meng, X.

Volltext

PCN47 INTEGRATION OF QUANTITATIVE SYSTEMS PHARMACOLOGY AND HEALTH ECONOMICS MODELS FOR DRUG DEVELOPMENT DECISION MAKING: APPLICATION TO TREATMENT OF SKELETAL RELATED EVENTS IN PATI... von Gastonguay, M., Riggs, M., Johnson, M.

Volltext

Population Pharmacokinetics of Ciprofloxacin in Pediatric Patients von Rajagopalan, Prabhu, Gastonguay, Marc R.

Volltext

295 POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE OF ALBINTERFERON ALFA-2B von Riggs, M, Bergsma, T, Rogers, J, Gastonguay, M, Subramanian, G, Chen, C, Devalaraja, M, Corey, A

Volltext

Effect of NONMEM minimization status and number of replicates on bootstrap parameter distributions for population pharmacokinetic models: A case study von Gastonguay, M. R., El‐Tahtawy, A.

Volltext

Evaluation of the effect of residual error covariance for a parent‐metabolite population pharmacokinetic model von Houk, B. E., Gastonguay, M. R., Amantea, M.

Volltext

Population pharmacokinetic‐pharmacodynamic modeling of efaproxiral in cancer patients receiving radiation therapy von Gastonguay, M. R., Venitz, J., Steffen, R., Hackman, J.

Volltext

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome von Moore, Jason N., Gastonguay, Marc R., Ng, Chee M., Adeniyi‐Jones, Susan C., Moody, David E., Fang, Wenfang B., Ehrlich, Michelle E., Kraft, Walter K.

Volltext

P385 Population pharmacokinetic modelling of vedolizumab in patients with ulcerative colitis or Crohn's disease von Rosario, M., Dirks, N., Gastonguay, M., Fox, I., Milton, A.

Volltext

Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia von SHI, Jun, LUDDEN, Thomas M, MELIKIAN, Armen P, GASTONGUAY, Marc R, HINDERLING, Peter H

Volltext

P489 Exposure-response relationship during vedolizumab induction therapy in adults with ulcerative colitis von Rosario, M., French, J., Dirks, N., Milton, A., Fox, I., Gastonguay, M.

Volltext

P488 Exposure-response relationship of vedolizumab after 6 weeks of treatment in adults with Crohn's disease von Rosario, M., French, J., Dirks, N., Milton, A., Fox, I., Gastonguay, M.

Volltext

Modeling uncertainty in clinical trial simulations: A bayesian approach von Gillespie, W.R., Sale, M., Gastonguay, M.R.

Volltext